m6A识别蛋白HNRNPC通过结合NF-κB上调CD80促肾小管上皮细胞凋亡在脓毒症相关急性肾损伤中的机制研究
批准号:
82100753
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
隽晨霞
依托单位:
学科分类:
继发性肾脏疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
隽晨霞
中文摘要
脓毒症相关急性肾损伤(S-AKI)是住院和重症患者的常见并发症,死亡率极高,缺乏有效的干预手段。m6A甲基化修饰在AKI中起重要作用,但其在S-AKI发病中的作用尚不明确。我们预实验发现m6A识别蛋白HNRNPC通过“m6A开关”机制可能参与S-AKI进程。.我们利用生信分析、细胞功能验证等方法,建立S-AKI体内外模型进行研究:炎症环境下肾小管上皮细胞CD80表达上调并促细胞凋亡,NF-κB参与CD80转录调控;炎症环境下肾小管上皮细胞m6A修饰水平升高,METTL3介导m6A甲基化修饰;m6A水平依赖性HNRNPC与NF-κB结合,调控下游基因CD80转录促肾小管细胞凋亡。因此我们提出假说:炎症环境下,m6A修饰水平改变,m6A识别蛋白HNRNPC通过结合NF-κB上调CD80,促肾小管上皮细胞凋亡,参与S-AKI的发病机制。.本研究可为干预S-AKI的发病及治疗靶点提供新的分子依据。
英文摘要
Sepsis-related acute kidney injury (S-AKI) is a common complication of hospitalized and critically ill patients, with extremely high mortality and lack of effective interventions. m6A methylation modification plays an important role in AKI, but its role in the pathogenesis of S-AKI is still unclear. Our preliminary experiments found that the m6A recognition protein HNRNPC may participate in the S-AKI process through the "m6A switch" mechanism..We use bio-information analysis and cell function verification to establish S-AKI in vivo and in vitro models for research: renal tubular epithelial cells CD80 expression was up-regulated and promote cell apoptosis in an inflammatory environment, and NF-κB participated in CD80 transcriptional regulation; the m6A modification level of renal tubular epithelial cells was increased under inflammatory conditions, and METTL3 mediated m6A methylation modification; m6A level-dependent HNRNPC binded to NF-κB, and regulated the transcription of downstream gene CD80 to promote renal tubular cell apoptosis. Therefore, we hypothesized that the m6A modification level changes in an inflammatory environment, and the m6A recognition protein HNRNPC up-regulates CD80 by binding to NF-κB, promotes the apoptosis of renal tubular epithelial cells, and participates in the pathogenesis of S-AKI..This study can provide a new molecular basis for intervention in the pathogenesis and therapeutic targets of S-AKI.
本项目以脓毒症相关急性肾损伤(Sepsis-associated Acute Kidney Injury, S-AKI)的发病机制为核心,聚焦RNA表观遗传修饰中的N6-甲基腺苷(m6A)修饰及其依赖性识别蛋白HNRNPC的调控作用。通过整合分子生物学技术、动物模型实验及数据分析,探讨炎症环境下m6A修饰如何通过HNRNPC调控NF-κB/CD80信号轴,促进肾小管上皮细胞的凋亡,为S-AKI的防治提供新理论和治疗靶点。. 研究结果显示,炎症刺激显著提高了肾小管上皮细胞mRNA的m6A修饰水平,该过程由关键甲基转移酶METTL3介导,并伴随m6A识别蛋白HNRNPC表达上调。HNRNPC通过结合NF-κB mRNA,促进其转录活性,进而上调下游效应基因CD80的表达,最终加剧细胞凋亡。体外实验中,敲低HNRNPC或抑制m6A修饰水平显著降低了NF-κB/CD80的表达,减少了炎症因子(IL-1β、IL-6、TNF-α)的释放,改善了细胞活性和形态学损伤。在脓毒症小鼠模型中,HNRNPC敲低显著缓解了肾脏炎症细胞浸润及细胞凋亡,改善了肾功能。. 项目创新性体现在以下几点:1)首次揭示m6A修饰水平通过“m6A开关”机制调控HNRNPC与NF-κB相互作用,形成S-AKI的重要病理环节;2)明确了NF-κB/CD80信号轴在S-AKI肾小管上皮细胞凋亡中的关键作用;3)基于表观遗传和信号通路干预策略,提出靶向HNRNPC的新型治疗方案。. 项目期间共发表SCI论文7篇,涵盖m6A修饰调控、细胞焦亡机制及肾损伤相关生物标志物开发等内容。此外,研究团队通过科普文章、视频和社区活动广泛传播S-AKI相关知识,提高了公众对肾损伤疾病及防治策略的认知。. 本项目研究成果不仅为脓毒症相关急性肾损伤的机制研究提供了新视角,还为该疾病的临床诊断及治疗干预奠定了坚实基础,具有重要的科学意义和应用潜力。
国内基金
海外基金